Author

Molly Olm-Shipman

Observed name: M. Olm-Shipman

Institution: University of Colorado Health

Observed institutions: Memorial Sloan Kettering Cancer Center, University of Colorado Health

OpenAlex ID: A5013772601

A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation

2018 · Alice Y. Ho, Molly Olm-Shipman, et al. · International Journal of Radiation Oncology*Biology*Physics · 92

Efficacy of Mometasone Furoate in the Reduction of Moderate/Severe Radiation Dermatitis in Breast Cancer Patients Following Mastectomy

2016 · M. Olm-Shipman, D. Gelblum, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

Works count: 2

Citation count: 94

H-index: 2

I10-index: 1